# Refine USA, LLC

- Location (FDA's records): Jacksonville Beach, FL
- FDA decisions: 2 (2012–2020): 2 510(k) clearances
- Product codes: QAI (1), ONQ (1)
- Predicates its devices cite: 2 (0 its own); citations of its devices by later devices: 0 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Bellus Medical, LLC: 1 (https://510kreport.com/company/bellus-medical)
- Newlands Clinical Trials, Ltd.: 1 (https://510kreport.com/company/newlands-clinical-trials)

## Recent decisions
- K192138: Rejuvapen NXT (Apr 9, 2020)
- K112334: Vein-Gogh Instrument (May 8, 2012)

Source page: https://510kreport.com/company/refine-usa